Investors in shares of Abbott Laboratories (NYSE:ABT) should contact the Shareholders Foundation in connection with the Lawsuit against Abbott Laboratories
SAN DIEGO, CA / ACCESSWIRE / November 8, 2022 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE:ABT shares.
Investors who purchased Abbott Laboratories (NYSE:ABT) shares prior to February 2021 and continue to hold any of their NYSE:ABT shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 31, 2022, a lawsuit was filed for certain investors in NYSE:ABT shares against Abbott Laboratories over alleged Securities Laws Violations. The plaintiff alleges that the Defendants made numerous materially false and misleading statements and omissions concerning what the U.S. Food and Drug Administration ("FDA") called "egregiously unsanitary" conditions at the Company's Sturgis facility, and that the Defendants repeatedly touted to investors the safety and salability of Abbott's infant formula brands and their contribution to the Company's sales and revenue growth.
Those who purchased Abbott Laboratories (NYSE:ABT) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.
View source version on accesswire.com:
https://www.accesswire.com/724502/Investors-in-shares-of-Abbott-Laboratories-NYSEABT-should-contact-the-Shareholders-Foundation-in-connection-with-the-Lawsuit-against-Abbott-Laboratories
